Literature DB >> 21262713

Observational study of 14 cases of chronic pancreatitis in dogs.

P J Watson1, J Archer, A J Roulois, T J Scase, M E Herrtage.   

Abstract

This study reports the clinical, clinicopathological and ultrasonographic findings from dogs with chronic pancreatitis (CP). Fourteen dogs with clinical signs consistent with CP and histological confirmation of the disease were evaluated. Abdominal ultrasound and clinical pathology results were recorded. Sensitivities of pancreatic enzymes for diagnosis of CP were calculated with two different cut-off values. The mean age of affected dogs was 9.1 years. Spaniels were the most common breed with CP, representing seven of the 14 dogs in this study. CP was histologically severe in nine cases. Most dogs showed chronic low-grade gastrointestinal signs and abdominal pain. Five dogs had exocrine pancreatic insufficiency and five dogs had diabetes mellitus. The sensitivity of elevated trypsin-like immunoreactivity for CP was 17 per cent. The sensitivities of canine pancreatic lipase immunoreactivity, lipase and amylase for CP were 44 to 67 per cent or 14 to 28 per cent depending on the cut-off value used. Cholesterol was elevated in 58 per cent of samples. Liver enzymes were often elevated. The pancreas appeared abnormal on 56 per cent of ultrasound examinations. Ten dogs had died by the end of the study period; only one case was due to CP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21262713     DOI: 10.1136/vr.c4912

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  9 in total

1.  Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?

Authors:  Allison L O'Kell; Clive Wasserfall; Brian Catchpole; Lucy J Davison; Rebecka S Hess; Jake A Kushner; Mark A Atkinson
Journal:  Diabetes       Date:  2017-06       Impact factor: 9.461

Review 2.  Laboratory tests for diagnosis of gastrointestinal and pancreatic diseases.

Authors:  Olivier Dossin
Journal:  Top Companion Anim Med       Date:  2011-05

3.  Prevalence of ultrasonographic gastrointestinal wall changes in dogs with acute pancreatitis: A retrospective study (2012-2020).

Authors:  Joshua J Hardwick; Elizabeth J Reeve; Melanie J Hezzell; Jenny A Reeve
Journal:  J Vet Intern Med       Date:  2022-03-23       Impact factor: 3.175

4.  Ultrasonographic Findings of Exocrine Pancreatic Insufficiency in Dogs.

Authors:  Tina Pelligra; Caterina Puccinelli; Veronica Marchetti; Simonetta Citi
Journal:  Vet Sci       Date:  2022-08-04

Review 5.  Corticosteroid treatment for acute/acute-on-chronic experimental and naturally occurring pancreatitis in several species: a scoping review to inform possible use in dogs.

Authors:  Kari-Anne Bjørnkjær-Nielsen; Charlotte Reinhard Bjørnvad
Journal:  Acta Vet Scand       Date:  2021-07-13       Impact factor: 1.695

6.  Evaluation of 1,2-O-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester (DGGR) and 1,2-diglyceride lipase assays in dogs with naturally occurring hypercortisolism.

Authors:  Guido Linari; Francesco Dondi; Sofia Segatore; Kateryna Vasylyeva; Nikolina Linta; Marco Pietra; Rodolfo O Leal; Federico Fracassi
Journal:  J Vet Diagn Invest       Date:  2021-06-02       Impact factor: 1.569

7.  Searching for "monogenic diabetes" in dogs using a candidate gene approach.

Authors:  Andrea D Short; Angela Holder; Simon Rothwell; Jonathan Massey; Rachel Scholey; Lorna J Kennedy; Brian Catchpole; William Er Ollier
Journal:  Canine Genet Epidemiol       Date:  2014-07-07

Review 8.  What's in a Name? Classification of Diabetes Mellitus in Veterinary Medicine and Why It Matters.

Authors:  C Gilor; S J M Niessen; E Furrow; S P DiBartola
Journal:  J Vet Intern Med       Date:  2016-07       Impact factor: 3.333

9.  Bile duct obstruction associated with pancreatitis in 46 dogs.

Authors:  Ashley R Wilkinson; Stefanie M DeMonaco; David L Panciera; Cristiane C Otoni; Michael S Leib; Martha M Larson
Journal:  J Vet Intern Med       Date:  2020-08-27       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.